Group Counseling for Smoking Cessation - Full Text View

Sponsored by:	American University
Information provided by:	American University
ClinicalTrials.gov Identifier:	NCT00104481

Purpose

The purpose of this study is to evaluate the effectiveness of group therapy for cigarette smoking cessation. The group meets for 8 sessions and includes education and group discussion about the effects of smoking and ways to cope with withdrawal symptoms and other challenges to maintaining abstinence. In one condition, the groups also learn techniques based on cognitive therapy, to help cope with negative feelings.

Condition	Intervention	Phase
Smoking	Behavioral: cognitive behavior therapy	Phase I Phase II

MedlinePlus related topics: Quitting Smoking Smoking

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Cognitive Behavior Therapy for Smoking Cessation

Further study details as provided by American University:

Primary Outcome Measures:

cigarette smoking abstinence

Secondary Outcome Measures:

cognitive coping skills
depressive symptoms
acceptance
distress tolerance

Estimated Enrollment:	240
Study Start Date:	January 2005
Estimated Study Completion Date:	August 2007

Detailed Description:

The comparison condition is the same length as the cognitive behavior therapy condition but omits the cognitive restructuring component. In both conditions, smokers prepare for a quit date by using scheduled reduced smoking, which involves smoking on a set schedule that gradually reduces the number of cigarettes smoked. Post-treatment assessments occur one week after the end of treatment, and at 3-month followup.

Pre- and post-treatment assessments include measures of coping skills and emotional acceptance, as well as smoking rate.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Regular daily smokers interested in quitting

Exclusion Criteria:

Significant suicidal ideation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00104481

Locations

United States, District of Columbia
American University
Washington, District of Columbia, United States, 20016-8062

Sponsors and Collaborators

American University

Investigators

Principal Investigator:

David A Haaga, Ph.D.

American University

More Information

Click here for more information about this study: Cognitive Behavior Therapy for Smoking Cessation This link exits the ClinicalTrials.gov site

This link exits the ClinicalTrials.gov site

Publications:

Haaga DA, Thorndike FP, Friedman-Wheeler DG, Pearlman MY, Wernicke RA. Cognitive coping skills and depression vulnerability among cigarette smokers. Addict Behav. 2004 Aug;29(6):1109-22.

Study ID Numbers:	2R15CA077732-02A1, 2R15CA077732-02A1
Study First Received:	March 1, 2005
Last Updated:	March 14, 2007
ClinicalTrials.gov Identifier:	NCT00104481
Health Authority:	United States: Institutional Review Board

Keywords provided by American University:

cognitive behavior therapy
coping
smoking cessation
acceptance

expectancies
quit smoking
quitting smoking

Study placed in the following topic categories:

Smoking

Additional relevant MeSH terms:

Habits

ClinicalTrials.gov processed this record on January 16, 2009